Posted on 6/10/18
Oncobiologics Closes Second Tranche of $15 Million Private Placement
CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it has closed on the second, and final, tranche of a $15.0 . . .
Posted on 6/10/18
iBio Announces Completion of 1-For-10 Reverse Stock Split
NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) announced today that its previously announced 1-for-10 reverse stock split of common stock became . . .
Posted on 6/10/18
Johnson & Johnson: Value In Plain Sight
Johnson & Johnson (JNJ) beat on both its top and bottom lines during its most recent quarter, but shares remain stagnant:Shares are still in "correction mode" . . .
Posted on 6/8/18
Where Will Cara Therapeutics, Inc. Be in 5 Years?
Clinical-stage biotechs can be veritable goldmines for patient investors. The caveat, however, is that it can immensely difficult to predict which companies are actually worth the . . .
Posted on 6/8/18
Pharmacy Times Ranks No. 1 Among Total Pharmacists
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading media resource for pharmacists and the pharmacy industry, is the most-read pharmacy journal among total pharmacists, according the 2018 Kantar . . .
Posted on 6/8/18
ADMA Biologics Announces Proposed Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) announced today that it has commenced an underwritten public offering . . .
Posted on 6/8/18
Agile Therapeutics Provides Corporate Update
PRINCETON, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women’s healthcare company, today announced several key corporate updates: Formal dispute resolution request . . .
Posted on 6/7/18
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ: OPHT) announced today that it has entered into an exclusive global license agreement with the University of Florida Research Foundation and . . .
Posted on 6/7/18
BioHiTech and Gold Medal Team Up
BioHiTech Global, Inc. (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced that Gold Medal Services, LLC, a market . . .
Posted on 6/6/18
CRG Completes Financing Transaction with Fast Pace Urgent Care
CRG, a leading healthcare investment firm, today announced a partnership with Fast Pace Urgent Care, a leading provider of urgent care clinics across rural Tennessee, Kentucky, . . .
Posted on 6/6/18
Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures
Pfizer Inc. (NYSE:PFE) today announced it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures,
Posted on 6/5/18
Five RMA of New York Physicians Recognized as "Best Doctors" by New York Magazine
A total of five physicians from Reproductive Medicine Associates of New York (RMA of New York) were listed in the 2018 edition of New York Magazine's . . .
Posted on 6/5/18
Teligent Closes $25 Million Secured Credit Facility
BUENA, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- TELIGENT, Inc. (NASDAQ:TLGT) Teligent, Inc. announced today that it has entered into a Credit Agreement with certain funds managed . . .
Posted on 6/5/18
Risalto Health Raises $1.5M
Risalto Health, a digital health company aiming to transform the delivery of musculoskeletal (MSK) care, has raised $1.5M in seed stage capital from New York-based Health . . .
Posted on 6/5/18
Celgene: Mr. Market Is Knocking, Presenting A Buying Opportunity
Founded in 1986, Celgene (Nasdaq: CELG) is a leading research company for medicines treating cancer and inflammatory disorders. For many years, Celgene was one of the . . .
Posted on 6/5/18
Merck Steals The Show At ASCO 2018 With Impressive Front-Line Lung Cancer Data
Recently, Merck (MRK) presented results from two late-stage trials in patients with non-small cell lung cancer (NSCLC) that were impressive. One late-stage study posted positive results . . .
Posted on 6/5/18
Could Celgene Shake Up the CAR-T Market?
The current CAR-T party of two might have a couple of new companions on the way. And those new entrants could bring some excitement to the . . .
Posted on 6/5/18
Quadrant Biosciences and ChoiceOne/MedSpring Urgent Care Enter Partnership
Quadrant Biosciences Inc. ("Quadrant Biosciences"), a Life Science company focused on functional assessment tools and epigenetic biomarkers for brain health and ChoiceOne/MedSpring, a leading Urgent Care . . .
Posted on 6/4/18
PENTAX Medical Enters Into Exclusive Distribution Agreement With CapsoVision in USA
PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today an exclusive distribution agreement with CapsoVision for their CapsoCam Plus Capsule Endoscopy . . .
Posted on 6/3/18
PAVmed Updates the Terms of Previously Announced Rights Offering
NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated, multiproduct medical device company, today announced that its board of directors has approved the following changes . . .
Posted on 6/1/18
Abeona Therapeutics Announces Opening of Commercial Gene & Cell Therapy Manufacturing Facility in Ohio
CLEVELAND and NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene and cell . . .
Posted on 5/31/18
ClearBridge Investments Sends Letter to Board of Directors of athenahealth
ClearBridge Investments, an investment affiliate of Legg Mason, Inc. [NYSE:LM], today announced that it has sent the following letter to the Board of Directors of athenahealth . . .
Posted on 5/31/18
iBio Announces Reverse Stock Split
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) announced today a reverse split of its Common Stock, par value $0.001 per share, . . .
Posted on 5/31/18
Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution
PARSIPPANY, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically . . .
Posted on 5/31/18
Akers Biosciences Granted 180-Day Extension by Nasdaq
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),, a developer of rapid health information technologies, announces that, on May . . .

